Medicine
Evotaz 300 mg/150 mg tablet
Evotaz 300 mg/150 mg tablet is a prescription medicine containing Atazanavir and Cobicistat for oral use, marketed by ER Squibb & Sons, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store EVOTAZ tablets at 25°C (77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Atazanavir and Cobicistat
- Brand
- Evotaz
- Strength
- 300 mg/150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- ER Squibb & Sons
- Manufacturer
- ER Squibb & Sons
- Origin register
- US FDA, United States
- Storage
- Store EVOTAZ tablets at 25°C (77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR15 Atazanavir and Cobicistat
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 January 2015
- Identifiers
- RxCUI 1601654, 1601660DailyMed set ID 83db29d7-5d85-49d6-8cb6-740473365cf8NDC 0003-3641Application NDA206353
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 0003-3641-11 | ER Squibb & Sons | 29 January 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Atazanavir and Cobicistat is a fixed-dose combination of a cytochrome P450 3A inhibitor and a protease inhibitor. It is available as tablets for oral use. MedsAcross supplies Atazanavir and Cobicistat for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Atazanavir and CobicistatFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EVOTAZ prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Evotaz: European public assessment report (EPAR) · European Medicines Agency
Need Evotaz 300 mg/150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.